Sailaja Puttagunta is an Infectious Disease physician affiliated with Fulcrum Therapeutics. OpenAlex indexes 67 publications with 2,613 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
56 Franklin St
Waterbury, CT 067061221
Telephone
203-709-6000Registry record last updated 17 Jul 2014.
Clinical trials
- Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women
Sponsor: Iterum Therapeutics, International Limited
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P-784. Risk Factors for Treatment Failure in Patients with Uncomplicated Urinary Tract Infection
Open Forum Infectious Diseases
2026 - <i>In vitro</i> activity and <i>in vivo</i> efficacy of sulopenem against <i>Bacillus anthracis</i> in inhalational anthrax mouse and rabbit models
Antimicrobial Agents and Chemotherapy
2026
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”